| Literature DB >> 17894274 |
Carlos Peña1, Kristen Bowsher, Ann Costello, Robert De Luca, Sara Doll, Khan Li, Marie Schroeder, Theodore Stevens.
Abstract
The United States Food and Drug Administration (FDA) is charged with assuring the safety and effectiveness of a variety of medical products and the FDA's Center for Devices and Radiological Health is responsible for premarket and postmarket regulation of medical devices. In this paper, we review--from device classification and clinical studies to the final marketing application--FDA's premarket requirements and postmarket requirements as they relate to deep brain stimulation devices.Mesh:
Year: 2007 PMID: 17894274 DOI: 10.1109/TNSRE.2007.903973
Source DB: PubMed Journal: IEEE Trans Neural Syst Rehabil Eng ISSN: 1534-4320 Impact factor: 3.802